KTTA - Pasithea Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KTTA is currently covered by 2 analysts with an average price target of $0.44. This is a potential upside of $-6.61 (-93.76%) from yesterday's end of day stock price of $7.05.

Pasithea Therapeutics Corp's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of KTTA is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for KTTA is $2, Lowest price target is $2, average price target is $0.44.

Most recent stock forecast was given by ELEMER PIROS from BENCHMARK on 10-Jul-2023. First documented stock forecast 03-Apr-2023.

Best performing analysts who are covering KTTA - Pasithea Therapeutics Corp:

Constantine Davides Elemer Piros

Currently out of the existing stock ratings of KTTA, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2

$-5.11 (-71.87%)

2

9 months 28 days ago

0/2 (0%)

$-7.22 (-78.31%)

Buy

2

$-5.11 (-71.87%)

1 years 1 months 5 days ago

0/1 (0%)

$-6 (-75.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KTTA (Pasithea Therapeutics Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?

CONSTANTINE DAVIDES

Which analyst has the current lower performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on KTTA (Pasithea Therapeutics Corp)?

Constantine Davides works at JMP and has 4 price targets and 3 ratings on KTTA

Which analyst is the currently most bullish on KTTA (Pasithea Therapeutics Corp)?

Elemer Piros with highest potential upside - $-5.11

Which analyst is the currently most reserved on KTTA (Pasithea Therapeutics Corp)?

Constantine Davides with lowest potential downside - -$5.11

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?